- Lobbying
- laboratory AND products
Lobbying Arrangements Results for 'Laboratory Products'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details health care policy and funding Health care policy and funding |
Bio Products Laboratory, LTD
|
STRATEGIC HEALTH CARE | |||
Details EPA Pesticide Policy |
FOREST PRODUCTS RESEARCH LABORATORY
|
ALSTON & BIRD, LLP | |||
Details Issues related to laboratory product services. Support R&D funding in appropriations. General issues related to laboratory products services. No specific legislation. |
Laboratory Products Association
|
PLATINUM ADVISORS DC, LLC | |||
Details EPA Pesticide Policy |
Bergeson & Campbell
Environmental Law |
Alston & Bird, LLP | |||
Details Issues related to Laboratory Services; appropriations |
Laboratory Products Association
|
Mercury Public Affairs, LLC | |||
Details -Medicare payment and coverage for clinical laboratory tests. |
Myriad Genetic Laboratories, Inc.
|
Foley Hoag, LLP | |||
Details H.R.6, 21st Century Cures Act. Oversight of laboratory services, genetic information and testing. Patient Protection and Affordable Care Act (P.L. 111-148) implementation. Medicare reimbursement re... |
Quest Diagnostics Incorporated
|
Rampy Northrup LLC | |||
Details Medicare coverage and reimbursement of laboratory tests. |
diaDexus Inc
Develops in vitro diagnostics products for cardiovascular disease. |
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details Issues related to clinical diagnostic laboratory services; S. 2333 Pandemic and All-Hazards Preparedness and Response Act, issues related to public health emergency preparedness; HR 4366-Fiscal Yea... |
Roche Diagnostics Corporation
|
Hooper, Lundy & Bookman, P.C. | |||
Details Medical diagnostic products and services. |
Diagnostic Test Work Group (DTWG)
|
Leavitt Partners, LLC | |||
Details Medicare reimbursement issues for post-acute care services and products; Medicare Part B competitive bidding issues; issues re: coverage and payment for rehabilitation services; issues pertaining t... |
National Association for the Support of Long Term Care
|
Arnall Golden Gregory, LLP | |||
Details Oversight of laboratory services and genetic information and testing. Patient Protection and Affordable Care Act implementation. Policies regarding drugs of abuse testing. Medicare reimbursement re... |
Quest Diagnostics Incorporated
|
PODESTA GROUP, INC. | |||
Details HR 2406, S 1117: ALIGN Act HR 2788, S 1232: The American Investment in Manufacturing (AIM) Act S 1706; Main Street Tax Certainty Act HR 3372: to amend Title 23, USC, to establish a safety data coll... |
Hardwood Federation
|
in-house lobbying | |||
Details Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software. |
Genomic Health, Inc.
|
Goldbug Strategies LLC | |||
Details Medicare competitive bidding program for durable medical equipment and supplies. Medicare payments for laboratory services. |
Roche Diagnostics Corporation, Inc.
|
MCDERMOTT WILL & EMERY LLP | |||
Details - Diagnostic regulatory reforms, including the Verifying Accurate Leading-edge IVCT Development Act of 2023 (H.R.2369) and the pilot program for Oncology Drug Products Used with Certain In Vitro Di... |
Foundation Medicine, Inc.
|
in-house lobbying | |||
Details Minimum Staffing Standards for Long-Term Care Facilities Physician Fee Schedule Reform Fee schedule conversion factor tied to inflation Eliminate the budget neutrality requirement Obtain an impact... |
ADVION (formerly National Association for the Support of Long Term Care)
|
in-house lobbying | |||
Details H.R. 2369: Verifying Accurate Leading-edge IVCT Development (VALID) Act; all provisions of the bill. H.R. 2377/S. 1000: Saving Access for Laboratory Services (SALSA) Act; all provisions of the bi... |
Thermo Fisher Scientific Inc.
|
in-house lobbying | |||
Details Issues related to global marketing restrictions. Issues related to laboratory developed tests. Issues related to the implementation of H.R. 6147 (115th Congress) - FY 2019 Appropriations; Issues re... |
Abbott Laboratories
|
Forbes-Tate | |||
Details H.R. 4394; S. 2443; Energy and Water Development Appropriations Bill, 2024; Title III, Department of Energy, all provisions and issues relating to the Department of Energy, and its science, energy,... |
BATTELLE MEMORIAL INSTITUTE
|
in-house lobbying | |||
Details Effectiveness and consumer transparency regarding air purifiers to improve indoor air quality, including federal funding for indoor air quality improvements and use of HEPA portable air purifiers i... |
Austin Air Systems, Limited
|
Capitol Counsel LLC | |||
Details (HCR) H.R. 2369 The Verifying Accurate Leading-edge IVCT Development Act, Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R. 3795 The... |
F. Hoffmann-La Roche Ltd, and Its Affiliates
|
in-house lobbying | |||
Details Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensurin... |
ADVANCED MEDICAL TECHNOLOGY ASSN
|
in-house lobbying | |||
Details Monitor implementation of P.L. 115-334, the Agriculture Act of 2018. Monitor progress of Livestock Mandatory Reporting Reauthorization. Monitor progress of S.949, "A bill to amend the Agricultura... |
National Pork Producers Council
|
in-house lobbying | |||
Details Promoting awareness of the biopharmaceutical and medical technology sectors. Opposing the imposition of price controls in the Medicare Part D program. Generally supporting intellectual property rig... |
HealthCare Institute of New Jersey
|
in-house lobbying | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
GSK (fka GLAXOSMITHKLINE INC.)
|
in-house lobbying | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
Pharmaceutical Research and Manufacturers of America
|
in-house lobbying | |||
Details Hill outreach to oppose site-neutral payment cuts; Hill outreach in support of the Acute Hospital Care at Home program; Hill outreach about streamlining prior authorization in Medicare Advantage pl... |
American Hospital Association
|
in-house lobbying |